Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-12 5:31 pm Sale |
2023-12-31 | 13G | Vigil Neuroscience, Inc. VIGL |
James E. Flynn | 1,173,523 3.270% |
-878,487 (-42.81%) |
Filing History |
| 2024-02-12 5:31 pm Sale |
2023-12-31 | 13G | Singular Genomics Systems, Inc. OMIC |
James E. Flynn | 250,496 6.830% |
-13,393 (-5.08%) |
Filing History |
| 2024-02-12 5:30 pm Sale |
2023-12-31 | 13G | Pulmonx Corporation LUNG |
James E. Flynn | 6,009 0.020% |
-2,459,254 (-99.76%) |
Filing History |
| 2024-02-12 5:30 pm Purchase |
2023-12-31 | 13G | Prelude Therapeutics Incorporated PRLD |
James E. Flynn | 4,133,000 9.850% |
910,310 (+28.25%) |
Filing History |
| 2024-02-12 5:29 pm Purchase |
2023-12-31 | 13G | Owens & Minor, Inc. OMI |
James E. Flynn | 5,229,779 6.840% |
1,027,112 (+24.44%) |
Filing History |
| 2024-02-12 5:28 pm Purchase |
2023-12-31 | 13G | Oscar Health, Inc. OSCR |
James E. Flynn | 11,246,820 5.890% |
709,329 (+6.73%) |
Filing History |
| 2024-02-12 5:27 pm Sale |
2023-12-31 | 13G | MALLINCKRODT PLC SHS MNKTQ |
James E. Flynn | 1,281,233 6.500% |
-224,736 (-14.92%) |
Filing History |
| 2024-02-12 5:27 pm Purchase |
2023-12-31 | 13G | HilleVax, Inc. HLVX |
James E. Flynn | 4,004,231 8.270% |
1,310,130 (+48.63%) |
Filing History |
| 2024-02-12 5:26 pm Purchase |
2023-12-31 | 13G | Enhabit, Inc. EHAB |
James E. Flynn | 4,997,746 9.970% |
2,001,746 (+66.81%) |
Filing History |
| 2024-02-12 5:26 pm Sale |
2023-12-31 | 13G | DocGo Inc. DCGO |
James E. Flynn | 5,320,139 5.120% |
-694,611 (-11.55%) |
Filing History |
| 2024-02-12 5:25 pm Sale |
2023-12-31 | 13G | Cabaletta Bio, Inc. CABA |
James E. Flynn | 2,007,729 4.690% |
-332,389 (-14.20%) |
Filing History |
| 2024-02-12 5:24 pm Purchase |
2023-12-31 | 13G | Brookdale Senior Living Inc. BKD |
James E. Flynn | 14,793,264 7.860% |
2,113,613 (+16.67%) |
Filing History |
| 2024-02-12 5:24 pm Sale |
2023-12-31 | 13G | Amedisys, Inc. AMED |
James E. Flynn | 0 0.000% |
-1,794,000 (Position Closed) |
Filing History |
| 2024-02-12 5:23 pm Purchase |
2023-12-31 | 13G | AdaptHealth Corp. AHCO |
James E. Flynn | 27,654,923 9.980% |
5,981,026 (+27.60%) |
Filing History |
| 2024-02-12 5:23 pm Sale |
2023-12-31 | 13G | Abeona Therapeutics Inc. ABEO |
James E. Flynn | 869,565 3.390% |
-869,565 (-50.00%) |
Filing History |
| 2024-02-01 5:29 pm Purchase |
2024-01-23 | 13G | CalciMedica, Inc. CALC |
James E. Flynn | 2,613,012 9.990% |
2,336,214 (+844.01%) |
Filing History |
| 2024-02-01 5:28 pm Purchase |
2024-01-23 | 13G | Edgewise Therapeutics, Inc. EWTX |
James E. Flynn | 4,478,592 5.250% |
545,455 (+13.87%) |
Filing History |
| 2024-02-01 5:26 pm Purchase |
2024-01-24 | 13G | Windtree Therapeutics, Inc. WINT |
James E. Flynn | 676 7.590% |
676 (New Position) |
Filing History |
| 2024-01-12 3:36 pm Purchase |
2024-01-11 | 13G | Solid Biosciences Inc. SLDB |
James E. Flynn | 2,260,398 6.080% |
2,260,398 (New Position) |
Filing History |
| 2023-12-18 4:45 pm Purchase |
2023-12-14 | 13G | Fusion Pharmaceuticals Inc. FUSN |
James E. Flynn | 6,401,000 8.840% |
6,401,000 (New Position) |
Filing History |